DE602006012310D1 - An titandioxidnanopartikeln absorbierte pharmazeutische wirkstoffe enthaltende pharmazeutische formulierungen - Google Patents

An titandioxidnanopartikeln absorbierte pharmazeutische wirkstoffe enthaltende pharmazeutische formulierungen

Info

Publication number
DE602006012310D1
DE602006012310D1 DE602006012310T DE602006012310T DE602006012310D1 DE 602006012310 D1 DE602006012310 D1 DE 602006012310D1 DE 602006012310 T DE602006012310 T DE 602006012310T DE 602006012310 T DE602006012310 T DE 602006012310T DE 602006012310 D1 DE602006012310 D1 DE 602006012310D1
Authority
DE
Germany
Prior art keywords
pharmaceutical
dioxide nanoparticles
titanium dioxide
pharmaceutical formulations
activities
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602006012310T
Other languages
English (en)
Inventor
Alberto Marra
Alessandro Dondoni
Carlo Alberto Bignozzi
Renato Canevotti
Gian Paolo Negrisoli
Valeria Dissette
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Flamma SpA
Original Assignee
Flamma SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flamma SpA filed Critical Flamma SpA
Publication of DE602006012310D1 publication Critical patent/DE602006012310D1/de
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE602006012310T 2005-05-26 2006-04-12 An titandioxidnanopartikeln absorbierte pharmazeutische wirkstoffe enthaltende pharmazeutische formulierungen Expired - Fee Related DE602006012310D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68453205P 2005-05-26 2005-05-26
PCT/EP2006/003348 WO2006125496A2 (en) 2005-05-26 2006-04-12 Pharmaceutical formulations comprising active pharmaceutical principles absorbed on titanium dioxide nanoparticles

Publications (1)

Publication Number Publication Date
DE602006012310D1 true DE602006012310D1 (de) 2010-04-01

Family

ID=37452388

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006012310T Expired - Fee Related DE602006012310D1 (de) 2005-05-26 2006-04-12 An titandioxidnanopartikeln absorbierte pharmazeutische wirkstoffe enthaltende pharmazeutische formulierungen

Country Status (5)

Country Link
US (1) US20080206347A1 (de)
EP (1) EP1888046B1 (de)
AT (1) ATE457721T1 (de)
DE (1) DE602006012310D1 (de)
WO (1) WO2006125496A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2081550B2 (de) 2006-03-09 2021-05-26 Reliant Pharmaceuticals, Inc. Beschichtung von kapseln mit pharmazeutischen wirkstoffen
WO2008135093A1 (en) * 2007-05-08 2008-11-13 Nm Tech Nanomaterials Microdevice Technology Ltd. Products comprising an anti-microbial composition based on titanium dioxide nanoparticles
FR2943539B1 (fr) * 2009-03-31 2011-07-22 Ethypharm Sa Composition pharmaceutique comprenant un macrolide immunosuppresseur de la famille des limus.
HUP1000299A2 (hu) 2010-06-08 2012-02-28 Nanoform Cardiovascular Therapeutics Ltd Nanostrukturált Atorvastatint, gyógyszerészetileg elfogadott sóit és kokristályait tartalmazó készítmény és eljárás elõállításukra
EP3084483A1 (de) 2013-12-19 2016-10-26 3M Innovative Properties Company Artikel mit selbstorganisierten schichten mit nanopartikeln mit einer phosphoroberflächenbehandlung
CN110090305A (zh) * 2019-03-15 2019-08-06 温州医科大学附属口腔医院 一种负载唑来膦酸的介孔二氧化钛

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2331097A1 (de) * 1973-06-19 1975-01-16 Battelle Institut E V Depotsystem fuer pharmazeutische oder kosmetische praeparate mit retardwirkung fuer aeusserliche anwendung
FR2451194A1 (fr) * 1979-03-16 1980-10-10 Merieux Inst Nouveau medicament a base de ganglioside notamment pour le traitement du cholera, et compositions pharmaceutiques le contenant
US6015801A (en) * 1997-07-22 2000-01-18 Merck & Co., Inc. Method for inhibiting bone resorption
US6086928A (en) * 1998-02-05 2000-07-11 Newly Weds Foods, Inc. Whitened food products and process for producing the same
AU2002364927A1 (en) * 2001-07-10 2003-06-30 North Carolina State University Nanoparticle delivery vehicle
WO2003032959A1 (en) * 2001-10-15 2003-04-24 Bosch William H Nanoparticulate compositions comprising inorganic cores
EP1653927B1 (de) * 2003-08-04 2012-01-11 Bend Research, Inc. Pharmazeutische zusammensetzungen von adsorbaten von amorphen arzneimitteln und lipophilen mikrophasen-bildenden materialien

Also Published As

Publication number Publication date
WO2006125496A3 (en) 2007-04-12
ATE457721T1 (de) 2010-03-15
WO2006125496A2 (en) 2006-11-30
US20080206347A1 (en) 2008-08-28
EP1888046B1 (de) 2010-02-17
EP1888046A2 (de) 2008-02-20

Similar Documents

Publication Publication Date Title
CU20080052A7 (es) Formas de presentación farmacéutica sólidas de administración oral con liberación rápida de principio activo
AP2012006231A0 (en) Capsule formulation of pirfenidone and pharmaceutically acceptable excipients.
CA3094580C (en) Oral formulations of cytidine analogs and methods of use thereof
IL195269A0 (en) Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
WO2011112229A3 (en) Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
DK1957110T3 (da) Fremgangsmåde til fremstilling af tygbare doseringsformer til lægemiddeladministration og produkter dermed
EP2444072A3 (de) Nichtmukoadhäsive Filmdosierungsformen
ECSP088560A (es) Formulacion de liberacion sostenida que comprende octreotida y dos o mas polimeros de polilactido-co-glicolido
MX2007002898A (es) Tableta con liberacion gastrointestinal controlada en sitio y tiempo del ingrediente activo.
IL191804A0 (en) Solid dispersion containing an active ingredient and tablets for oral administration containing the same
DE602006012310D1 (de) An titandioxidnanopartikeln absorbierte pharmazeutische wirkstoffe enthaltende pharmazeutische formulierungen
MY139086A (en) Use of debranched starch in extrusion-spheronization pharmaceutical pellets
FR2904219B1 (fr) Microparticules a base de copolymere amphiphile et de principe(s) actif(s) a liberation modifiee et formulations pharmaceutiques en contenant
MY146988A (en) Fexofenadine suspension formulation
ATE498396T1 (de) Pharmazeutische formulierung zur behandlung des oberen verdauungstraktes
WO2010127205A3 (en) Fixed dose drug combination formulations
WO2011151722A3 (en) Methods and compositions for oral pharmaceutical therapy
IL201465A0 (en) Self-precipitating pharmaceutical formulations for the modified release of active principle
ATE439832T1 (de) Feste pharmazeutische arzneimittelformulierung enthaltend diacerein und meloxicam
NO20071806L (no) Tabletter med steds- og tidsregulert gastrointestinal frigivelse av aktiv bestanddel.
HK1120417A1 (en) Stable nanoparticle formulations
ITMI20051231A1 (it) Formulazioni farmaceutiche contenenti colostro e calcio folinato per il trattamento delle affezioni del cavo orale
ECSP109871A (es) Soluciones farmacéuticas orales que contienen telbivudina
BRPI0810878A2 (pt) Partículas à base de polieletrólitos e de princípio ativo de liberação modificada e formulações farmacêuticas contendo estas partículas.

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee